Clinical Trials Directory

Trials / Completed

CompletedNCT01754350

Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma

Calorie-restricted, Ketogenic Diet and Transient Fasting vs. Standard Nutrition During Reirradiation for Patients With Recurrent Glioblastoma: the ERGO2 Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Increased glucose metabolism is characteristic for solid tumors. Thereby, glucose is important for the generation of ATP, supply of anabolic substrates and defense against reactive oxygen species in tumor cells. In preclinical models, restricting glucose availability using a ketogenic diet, calorie-restriction or transient fasting inhibits tumor growth. Therefore, the purpose of the study is to evaluate whether a calorie-restricted, ketogenic diet and transient fasting can enhance the efficacy of reirradiation in patients with recurrent glioblastoma.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcalorie-restricted ketogenic diet and transient fastingOn day 1-3 and day 7-9, restriction of carbohydrates to \< 60 g and of calories to 21-23 kcal/kg per day, on day 4-6 fasting. On day 1-3 and 7-9, restriction of carbohydrates can be supported by the use of drinks provided by "Tavarlin".
DIETARY_SUPPLEMENTstandard nutritionnutrition as recommended by the german society for nutrition, 30 kcal/kg per day

Timeline

Start date
2013-05-01
Primary completion
2017-12-01
Completion
2019-03-01
First posted
2012-12-21
Last updated
2021-06-02
Results posted
2021-06-02

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01754350. Inclusion in this directory is not an endorsement.